281 related articles for article (PubMed ID: 15814586)
21. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines.
Kastury K; Baffa R; Druck T; Ohta M; Cotticelli MG; Inoue H; Negrini M; Rugge M; Huang D; Croce CM; Palazzo J; Huebner K
Cancer Res; 1996 Mar; 56(5):978-83. PubMed ID: 8640789
[TBL] [Abstract][Full Text] [Related]
22. Direct correlation between FRA3B expression and cigarette smoking.
Stein CK; Glover TW; Palmer JL; Glisson BS
Genes Chromosomes Cancer; 2002 Jul; 34(3):333-40. PubMed ID: 12007194
[TBL] [Abstract][Full Text] [Related]
23. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.
Shridhar R; Shridhar V; Wang X; Paradee W; Dugan M; Sarkar F; Wilke C; Glover TW; Vaitkevicius VK; Smith DI
Cancer Res; 1996 Oct; 56(19):4347-50. PubMed ID: 8813121
[TBL] [Abstract][Full Text] [Related]
24. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1.
Krummel KA; Denison SR; Calhoun E; Phillips LA; Smith DI
Genes Chromosomes Cancer; 2002 Jun; 34(2):154-67. PubMed ID: 11979549
[TBL] [Abstract][Full Text] [Related]
25. Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX.
Alsop AE; Taylor K; Zhang J; Gabra H; Paige AJ; Edwards PA
Genes Chromosomes Cancer; 2008 May; 47(5):437-47. PubMed ID: 18273838
[TBL] [Abstract][Full Text] [Related]
26. WWOX, the FRA16D gene: A target of and a contributor to genomic instability.
Hussain T; Liu B; Shrock MS; Williams T; Aldaz CM
Genes Chromosomes Cancer; 2019 May; 58(5):324-338. PubMed ID: 30350478
[TBL] [Abstract][Full Text] [Related]
27. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors.
Morelli C; Karayianni E; Magnanini C; Mungall AJ; Thorland E; Negrini M; Smith DI; Barbanti-Brodano G
Oncogene; 2002 Oct; 21(47):7266-76. PubMed ID: 12370818
[TBL] [Abstract][Full Text] [Related]
28. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
29. WWOX, the common chromosomal fragile site, FRA16D, cancer gene.
Ludes-Meyers JH; Bednarek AK; Popescu NC; Bedford M; Aldaz CM
Cytogenet Genome Res; 2003; 100(1-4):101-10. PubMed ID: 14526170
[TBL] [Abstract][Full Text] [Related]
30. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer.
Lin H; Pizer ES; Morin PJ
Genomics; 2000 Nov; 69(3):391-4. PubMed ID: 11056057
[TBL] [Abstract][Full Text] [Related]
31. Biallelic deletion and loss of expression analysis of genes at FRA2G common fragile site in tumor-derived cell lines.
Limongi ZM; Curatolo A; Pelliccia F; Rocchi A
Cancer Genet Cytogenet; 2005 Sep; 161(2):181-6. PubMed ID: 16102592
[TBL] [Abstract][Full Text] [Related]
32. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract][Full Text] [Related]
33. A survey of homozygous deletions in human cancer genomes.
Cox C; Bignell G; Greenman C; Stabenau A; Warren W; Stephens P; Davies H; Watt S; Teague J; Edkins S; Birney E; Easton DF; Wooster R; Futreal PA; Stratton MR
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4542-7. PubMed ID: 15761058
[TBL] [Abstract][Full Text] [Related]
34. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
[TBL] [Abstract][Full Text] [Related]
35. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
[TBL] [Abstract][Full Text] [Related]
36. RORA, a large common fragile site gene, is involved in cellular stress response.
Zhu Y; McAvoy S; Kuhn R; Smith DI
Oncogene; 2006 May; 25(20):2901-8. PubMed ID: 16462772
[TBL] [Abstract][Full Text] [Related]
37. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
[TBL] [Abstract][Full Text] [Related]
38. A novel approach to simultaneously scan genes at fragile sites.
Willem P; Brown J; Schouten J
BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
[TBL] [Abstract][Full Text] [Related]
39. Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions.
Wang L; Paradee W; Mullins C; Shridhar R; Rosati R; Wilke CM; Glover TW; Smith DI
Genomics; 1997 May; 41(3):485-8. PubMed ID: 9169152
[TBL] [Abstract][Full Text] [Related]
40. WWOX, the tumour suppressor gene affected in multiple cancers.
Lewandowska U; Zelazowski M; Seta K; Byczewska M; Pluciennik E; Bednarek AK
J Physiol Pharmacol; 2009 May; 60 Suppl 1():47-56. PubMed ID: 19609013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
